A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults

BACKGROUND: This first in human study was designed as an open label clinical trial to assess safety and tolerability of Serum Institute of India Pvt. Ltd. (SIIPL) quadrivalent HPV (qHPV) vaccine. METHODS: A total of 48 healthy male and female (24 each) adult volunteers were administered a 0.5 ml sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Hitt, Anil, K., Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Desai, Shivani, Madhusudhan, R.L., Patel, Jaya, Eswaraiah, Anand, Rao, Harish, Gairola, Sunil, Shaligram, Umesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205786/
https://www.ncbi.nlm.nih.gov/pubmed/37234594
http://dx.doi.org/10.1016/j.jvacx.2023.100313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205786/
https://www.ncbi.nlm.nih.gov/pubmed/37234594
http://dx.doi.org/10.1016/j.jvacx.2023.100313

Ejemplares similares